Applied biotechnology is an area of science with immense growth due to the emerging need for bio-products produced using renewable resources which are therefore sustainable, leading to a strong bio-economy. Bio-products include biofuels, biopolymers, chemicals, pharmaceuticals, nutraceuticals, food and textiles. A major application for these products is in medicine, for example in tissue engineering, medical implants, novel drug development and controlled drug delivery.
The Applied Biotechnology Research Group (ABRG) aims towards the exploitation of biological resources for the production and development of a range of bio-products and their use for environmental, medical and chemical/biochemical applications.
This research group has international repute in several areas including: biopolymer production, biomaterials, scaling up of bioprocesses, bioprocess optimisation, antibiotic production, green chemistry including environmentally friendly dye remediation, enzyme technology, biofuels, small molecule production including chiral compounds, antibacterial products of natural origin, antibacterial materials, exploitation of plant and algal resources, plant structure, quorum sensing, drug delivery, tissue engineering (cardiac, nerve, bone, cartilage, skin), medical device development and wound healing.
ABRG thus covers a range of priority areas outlined by the RCUK and the EU including: Energy, Global Food Security, Lifelong Health and Wellbeing (RCUK Interdisciplinary priority areas) and Biotechnology, nanotechnology, Health, demographic change and well-being; Food security, sustainable agriculture, marine and maritime research and the bio-based economy; Secure, clean and efficient energy (some of the EU priority areas listed in Horizon 2020).
Ipsita Roy, A PARK fund for patent application from WESTFOCUS, London, UK, 15,000
Tajalli Keshavarz, QUORUM, Discovering Quorum Sensing in industrially useful Fungi, a novel approach at molecular level for scaling up in white biotech. An EU FP6 project, 350,000.